Duyuru • May 15
KNC Laboratories Co., Ltd., Annual General Meeting, Jun 24, 2026 KNC Laboratories Co., Ltd., Annual General Meeting, Jun 24, 2026. Duyuru • May 10
KNC Laboratories Co., Ltd. to Report Fiscal Year 2026 Results on May 14, 2026 KNC Laboratories Co., Ltd. announced that they will report fiscal year 2026 results on May 14, 2026 Upcoming Dividend • Mar 23
Upcoming dividend of JP¥17.00 per share Eligible shareholders must have bought the stock before 30 March 2026. Payment date: 25 June 2026. Trailing yield: 2.6%. Lower than top quartile of Japanese dividend payers (3.6%). Higher than average of industry peers (2.3%). Duyuru • Dec 02
KNC Laboratories Co., Ltd. to Report Q3, 2026 Results on Feb 13, 2026 KNC Laboratories Co., Ltd. announced that they will report Q3, 2026 results on Feb 13, 2026 Duyuru • Oct 07
KNC Laboratories Co., Ltd. to Report Q2, 2026 Results on Nov 14, 2025 KNC Laboratories Co., Ltd. announced that they will report Q2, 2026 results on Nov 14, 2025 Upcoming Dividend • Sep 22
Upcoming dividend of JP¥16.00 per share Eligible shareholders must have bought the stock before 29 September 2025. Payment date: 08 December 2025. Trailing yield: 2.8%. Lower than top quartile of Japanese dividend payers (3.6%). In line with average of industry peers (2.6%). Duyuru • Jun 04
KNC Laboratories Co., Ltd. to Report Q1, 2026 Results on Aug 08, 2025 KNC Laboratories Co., Ltd. announced that they will report Q1, 2026 results on Aug 08, 2025 Duyuru • May 13
KNC Laboratories Co., Ltd., Annual General Meeting, Jun 24, 2025 KNC Laboratories Co., Ltd., Annual General Meeting, Jun 24, 2025. Upcoming Dividend • Mar 21
Upcoming dividend of JP¥17.00 per share Eligible shareholders must have bought the stock before 28 March 2025. Payment date: 26 June 2025. Trailing yield: 2.8%. Lower than top quartile of Japanese dividend payers (3.7%). In line with average of industry peers (2.6%). Duyuru • Feb 28
KNC Laboratories Co., Ltd. to Report Fiscal Year 2025 Results on May 13, 2025 KNC Laboratories Co., Ltd. announced that they will report fiscal year 2025 results on May 13, 2025 Duyuru • Jan 17
KNC Laboratories Co., Ltd. to Report Q3, 2025 Results on Feb 14, 2025 KNC Laboratories Co., Ltd. announced that they will report Q3, 2025 results on Feb 14, 2025 Upcoming Dividend • Sep 20
Upcoming dividend of JP¥16.00 per share Eligible shareholders must have bought the stock before 27 September 2024. Payment date: 05 December 2024. Trailing yield: 2.6%. Lower than top quartile of Japanese dividend payers (3.8%). In line with average of industry peers (2.4%). Duyuru • Aug 24
KNC Laboratories Co., Ltd. to Report Q2, 2025 Results on Nov 08, 2024 KNC Laboratories Co., Ltd. announced that they will report Q2, 2025 results on Nov 08, 2024 New Risk • Aug 05
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Japanese stocks, typically moving 5.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Latest financial reports are more than 1 year old (reported March 2016 fiscal period end). Minor Risks Short dividend paying track record (1 year of continuous dividend payments). Share price has been volatile over the past 3 months (5.8% average weekly change). Market cap is less than US$100m (JP¥7.89b market cap, or US$55.4m). Duyuru • May 25
KNC Laboratories Co., Ltd. to Report Q1, 2025 Results on Aug 09, 2024 KNC Laboratories Co., Ltd. announced that they will report Q1, 2025 results on Aug 09, 2024 Duyuru • May 15
KNC Laboratories Co., Ltd., Annual General Meeting, Jun 25, 2024 KNC Laboratories Co., Ltd., Annual General Meeting, Jun 25, 2024. Upcoming Dividend • Mar 21
Upcoming dividend of JP¥15.00 per share Eligible shareholders must have bought the stock before 28 March 2024. Payment date: 24 June 2024. Trailing yield: 2.1%. Lower than top quartile of Japanese dividend payers (3.2%). In line with average of industry peers (2.1%). Duyuru • Mar 15
KNC Laboratories Co., Ltd. (TSE:6568) acquired an unknown stake in NapaJen Pharma, Inc. from INCJ, Ltd. KNC Laboratories Co., Ltd. (TSE:6568) acquired an unknown stake in NapaJen Pharma, Inc. from INCJ, Ltd. on March 14, 2024.KNC Laboratories Co., Ltd. (TSE:6568) completed the acquisition of an unknown stake in NapaJen Pharma, Inc. from INCJ, Ltd. on March 14, 2024. Duyuru • Mar 02
KNC Laboratories Co., Ltd. to Report Fiscal Year 2024 Results on May 13, 2024 KNC Laboratories Co., Ltd. announced that they will report fiscal year 2024 results on May 13, 2024 Duyuru • Nov 19
KNC Laboratories Co., Ltd. to Report Q3, 2024 Results on Feb 09, 2024 KNC Laboratories Co., Ltd. announced that they will report Q3, 2024 results on Feb 09, 2024 Upcoming Dividend • Sep 21
Inaugural dividend of JP¥15.00 per share Eligible shareholders must have bought the stock before 28 September 2023. Payment date: 06 December 2023. This is the first dividend for KNC Laboratories since going public. The average dividend yield among industry peers is 2.5%. Duyuru • Aug 19
KNC Laboratories Co., Ltd. to Report Q2, 2024 Results on Oct 11, 2023 KNC Laboratories Co., Ltd. announced that they will report Q2, 2024 results on Oct 11, 2023 Duyuru • Jun 03
KNC Laboratories Co., Ltd. to Report Q1, 2024 Results on Aug 10, 2023 KNC Laboratories Co., Ltd. announced that they will report Q1, 2024 results on Aug 10, 2023 Duyuru • May 14
KNC Laboratories Co., Ltd., Annual General Meeting, Jun 22, 2023 KNC Laboratories Co., Ltd., Annual General Meeting, Jun 22, 2023. Upcoming Dividend • Mar 23
Inaugural dividend of JP¥18.00 per share Eligible shareholders must have bought the stock before 30 March 2023. Payment date: 26 June 2023. This is the first dividend for KNC Laboratories since going public. The average dividend yield among industry peers is 2.8%. Duyuru • Dec 17
KNC Laboratories Co., Ltd. to Report Q3, 2023 Results on Feb 10, 2023 KNC Laboratories Co., Ltd. announced that they will report Q3, 2023 results on Feb 10, 2023 Board Change • Nov 16
No independent directors Following the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 6 non-independent directors. Director of Fine Chemical Division & Director Hidemi Yoshida was the last director to join the board, commencing their role in 2022. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model. Duyuru • Sep 01
KNC Laboratories Co., Ltd. to Report Q2, 2023 Results on Nov 11, 2022 KNC Laboratories Co., Ltd. announced that they will report Q2, 2023 results on Nov 11, 2022 Duyuru • Jun 02
KNC Laboratories Co., Ltd. to Report Q1, 2023 Results on Aug 10, 2022 KNC Laboratories Co., Ltd. announced that they will report Q1, 2023 results on Aug 10, 2022 Duyuru • May 18
KNC Laboratories Co., Ltd., Annual General Meeting, Jun 23, 2022 KNC Laboratories Co., Ltd., Annual General Meeting, Jun 23, 2022. Board Change • Apr 27
No independent directors Following the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 8 non-independent directors. Director Kimio Yasuda was the last director to join the board, commencing their role in 2021. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model. Duyuru • Apr 08
KNC Laboratories Co., Ltd. to Report Fiscal Year 2022 Results on May 13, 2022 KNC Laboratories Co., Ltd. announced that they will report fiscal year 2022 results on May 13, 2022 Upcoming Dividend • Mar 23
Upcoming dividend of JP¥25.00 per share Eligible shareholders must have bought the stock before 30 March 2022. Payment date: 25 June 2022. The company is not currently making a profit and is not cash flow positive. Trailing yield: 2.3%. Lower than top quartile of Japanese dividend payers (3.4%). Lower than average of industry peers (2.6%). Upcoming Dividend • Mar 23
Inaugural dividend of JP¥25.00 per share Eligible shareholders must have bought the stock before 30 March 2021. Payment date: 25 June 2021. This is the first dividend for KNC Laboratories since going public. The average dividend yield among industry peers is 1.8%. Duyuru • Mar 05
KNC Laboratories Co., Ltd. to Report Fiscal Year 2021 Results on May 13, 2021 KNC Laboratories Co., Ltd. announced that they will report fiscal year 2021 results on May 13, 2021 Is New 90 Day High Low • Feb 15
New 90-day low: JP¥1,526 The company is down 9.0% from its price of JP¥1,678 on 17 November 2020. The Japanese market is up 11% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 11% over the same period. Duyuru • Dec 12
KNC Laboratories Co., Ltd. to Report Q3, 2021 Results on Feb 12, 2021 KNC Laboratories Co., Ltd. announced that they will report Q3, 2021 results on Feb 12, 2021 Duyuru • Sep 13
KNC Laboratories Co., Ltd. to Report Q2, 2021 Results on Nov 13, 2020 KNC Laboratories Co., Ltd. announced that they will report Q2, 2021 results on Nov 13, 2020 Duyuru • Jun 29
KNC Laboratories Co., Ltd. to Report Q1, 2021 Results on Aug 07, 2020 KNC Laboratories Co., Ltd. announced that they will report Q1, 2021 results on Aug 07, 2020